APA (7th ed.) Citation

Zeng, Y., Liu, L., Zhu, L., Zhan, X., Peng, F., Feng, X., . . . Wen, Y. (2022). Proton pump inhibitor usage is associated with higher all-cause mortality and CV events in peritoneal dialysis patients. Renal Failure, 44(1), 398. https://doi.org/10.1080/0886022X.2022.2043903

Chicago Style (17th ed.) Citation

Zeng, Yingsi, et al. "Proton Pump Inhibitor Usage Is Associated with Higher All-cause Mortality and CV Events in Peritoneal Dialysis Patients." Renal Failure 44, no. 1 (2022): 398. https://doi.org/10.1080/0886022X.2022.2043903.

MLA (9th ed.) Citation

Zeng, Yingsi, et al. "Proton Pump Inhibitor Usage Is Associated with Higher All-cause Mortality and CV Events in Peritoneal Dialysis Patients." Renal Failure, vol. 44, no. 1, 2022, p. 398, https://doi.org/10.1080/0886022X.2022.2043903.